These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 22407829)
1. Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Perez-Moreno P; Brambilla E; Thomas R; Soria JC Clin Cancer Res; 2012 May; 18(9):2443-51. PubMed ID: 22407829 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens. Ocque R; Tochigi N; Ohori NP; Dacic S Am J Clin Pathol; 2011 Jul; 136(1):81-7. PubMed ID: 21685035 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping. Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118 [TBL] [Abstract][Full Text] [Related]
5. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component. Ohtsuka K; Ohnishi H; Fujiwara M; Kishino T; Matsushima S; Furuyashiki G; Takei H; Koshiishi Y; Goya T; Watanabe T Cancer; 2007 Feb; 109(4):741-50. PubMed ID: 17238183 [TBL] [Abstract][Full Text] [Related]
6. Squamous-cell carcinoma of the lungs: is it really so different? Sereno M; Esteban IR; Zambrana F; Merino M; Gómez-Raposo C; López-Gómez M; Sáenz EC Crit Rev Oncol Hematol; 2012 Dec; 84(3):327-39. PubMed ID: 22819280 [TBL] [Abstract][Full Text] [Related]
8. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273 [TBL] [Abstract][Full Text] [Related]
10. The importance of pathology for prognosis and management in lung cancer. Yesner R Conn Med; 1975 May; 39(5):280-3. PubMed ID: 165034 [No Abstract] [Full Text] [Related]
11. Beyond adenocarcinoma: current treatments and future directions for squamous, small cell, and rare lung cancer histologies. Gerber DE; Paik PK; Dowlati A Am Soc Clin Oncol Educ Book; 2015; ():147-62. PubMed ID: 25993153 [TBL] [Abstract][Full Text] [Related]
12. Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence. Tai AL; Yan WS; Fang Y; Xie D; Sham JS; Guan XY Cancer; 2004 May; 100(9):1918-27. PubMed ID: 15112273 [TBL] [Abstract][Full Text] [Related]
13. Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level? Bastide K; Ugolin N; Levalois C; Bernaudin JF; Chevillard S Lung Cancer; 2010 Apr; 68(1):1-9. PubMed ID: 20004040 [TBL] [Abstract][Full Text] [Related]
14. What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements. Cooper WA; O'toole S; Boyer M; Horvath L; Mahar A Pathology; 2011 Feb; 43(2):103-15. PubMed ID: 21233671 [TBL] [Abstract][Full Text] [Related]
15. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma. Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359 [TBL] [Abstract][Full Text] [Related]
16. [Pathological variability and cancer treatment in lung cancer]. Kodama T Gan To Kagaku Ryoho; 1986 Sep; 13(9):2708-17. PubMed ID: 3019250 [TBL] [Abstract][Full Text] [Related]
17. Common and contrasting genomic profiles among the major human lung cancer subtypes. Tonon G; Brennan C; Protopopov A; Maulik G; Feng B; Zhang Y; Khatry DB; You MJ; Aguirre AJ; Martin ES; Yang Z; Ji H; Chin L; Wong KK; Depinho RA Cold Spring Harb Symp Quant Biol; 2005; 70():11-24. PubMed ID: 16869734 [TBL] [Abstract][Full Text] [Related]
18. Assessment of molecular events in squamous and non-squamous cell lung carcinoma. Yakut T; Schulten HJ; Demir A; Frank D; Danner B; Egeli U; Gebitekin C; Kahler E; Gunawan B; Urer N; Oztürk H; Füzesi L Lung Cancer; 2006 Dec; 54(3):293-301. PubMed ID: 17011066 [TBL] [Abstract][Full Text] [Related]
19. Lung cancer: progress in diagnosis and treatment. Carney DN Ir Med J; 1984 Oct; 77(10):327-9. PubMed ID: 6094392 [No Abstract] [Full Text] [Related]
20. Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review. Field RW; Smith BJ; Platz CE; Robinson RA; Neuberger JS; Brus CP; Lynch CF J Natl Cancer Inst; 2004 Jul; 96(14):1105-7. PubMed ID: 15265973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]